MorphoSys AG
NASDAQ: MOR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Arkadius Pichota
- Employees
- 464
- Headquarters
- Planegg, Germany
- IPO year
- 2018
- Market cap
- $2.9B
- Website
- https://www.morphosys.com
Loading MOR…
Loading profile data…Frequently asked questions about MOR
What does MorphoSys AG (MOR) do?
MorphoSys AG is a commercial-stage biopharmaceutical company dedicated to the discovery, advancement, and marketing of innovative therapeutic antibodies aimed at treating cancer and autoimmune disorders. While its commercial operations are primarily situated in the United States, its development and partnership activities span globally. A key co...
Where does MOR trade?
MorphoSys AG (MOR) trades on the NASDAQ Global Select.
What sector is MOR in?
MorphoSys AG (MOR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MorphoSys AG?
Arkadius Pichota is the chief executive officer of MorphoSys AG (MOR).
Where is MorphoSys AG headquartered?
MorphoSys AG is headquartered in Germany.
Does MOR pay a dividend?
MorphoSys AG (MOR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MOR go public?
MorphoSys AG (MOR) completed its initial public offering in 2018.
Is MOR an ADR?
Yes — MOR is an American Depositary Receipt; its underlying shares trade on a non-US exchange. MorphoSys AG reporting and dividends follow the underlying issuer.